Calcitonin gene-related peptide predicts therapeutic response to midodrine hydrochloride in children with vasovagal syncope

The vasoconstriction agent midodrine hydrochloride is a vital treatment for pediatric patients diagnosed with vasovagal syncope (VVS), although the efficacy is variable. This study was designed to explore the value of calcitonin gene-related peptide (CGRP) in predicting the effect of midodrine hydro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lintian, Zhao, Huacai, Ma, Xiuxiu, Jiao, Fuyong, Lin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577468/
https://www.ncbi.nlm.nih.gov/pubmed/36267231
http://dx.doi.org/10.3389/fnins.2022.1026539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577468/
https://www.ncbi.nlm.nih.gov/pubmed/36267231
http://dx.doi.org/10.3389/fnins.2022.1026539

Ejemplares similares